Eli Lilly & Co. (LLY)

1042.15 -16.41 (-1.55%) USD  |  NYSE  |  Feb 24, 16:00
1042.50 +0.35 (+0.03%) Pre-Market: 06:29
More

Eli Lilly Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. --
Moderna, Inc. Upgrade